Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1478-811X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis ; volume:18 ; number:1 ; day:24 ; month:1 ; year:2020 ; pages:1-18 ; date:12.2020
Cell communication and signaling ; 18, Heft 1 (24.1.2020), 1-18, 12.2020

Creator
Neuwirt, Hannes
Bouchal, Jan
Kharaishvili, Gvantsa
Ploner, Christian
Jöhrer, Karin
Pitterl, Florian
Weber, Anja
Klocker, Helmut
Eder, Iris E.
Contributor
SpringerLink (Online service)

DOI
10.1186/s12964-019-0505-5
URN
urn:nbn:de:101:1-2020043022493351587868
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Neuwirt, Hannes
  • Bouchal, Jan
  • Kharaishvili, Gvantsa
  • Ploner, Christian
  • Jöhrer, Karin
  • Pitterl, Florian
  • Weber, Anja
  • Klocker, Helmut
  • Eder, Iris E.
  • SpringerLink (Online service)

Other Objects (12)

Biomarkers for cancer-associated fibroblasts

Biomarkers for cancer-associated fibroblasts

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma

Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development

Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development

Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?

Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?

Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets

Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets

Advances of cancer-associated fibroblasts in liver cancer

Advances of cancer-associated fibroblasts in liver cancer

Comparative transcriptome of normal and cancer-associated fibroblasts

Comparative transcriptome of normal and cancer-associated fibroblasts

SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts

SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts

Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities

Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities

Galectin-1 from cancer-associated fibroblasts induces epithelial–mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer

Galectin-1 from cancer-associated fibroblasts induces epithelial–mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer

Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts

Identification of Molecular Distinctions Between Normal Breast-Associated Fibroblasts and Breast Cancer-Associated Fibroblasts

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

Related objects